A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation

Condition:   Dwarfism Intervention:   Drug: Recombinant Human Growth Hormone Injection (rhGH) Sponsors:   GeneScience Pharmaceuticals Co., Ltd.;   Children's Hospital of Fudan University;   Beijing Children's Hospital;   Children's Hospital of Shanghai;   Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;   The Children's Hospital, Zhejiang University S chool Of Medicine;   Children's hospital capital institute of pediatrics;   Peking University First Hospital;   Fuzhou General Hospital;   The First Affiliated Hospital of Zhengzhou University;   Shengjing Hospital;   Children's Hospital of Chongqing Medical University;   Tongji medical college huazhong university of science& technology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials